Search Results - "Blundell, M.P"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Correction of SCID-X1 using an enhancerless Vav promoter by Almarza, E, Zhang, F, Santilli, G, Blundell, M P, Howe, S J, Thornhill, S I, Bueren, J A, Thrasher, A J

    Published in Human gene therapy (01-03-2011)
    “…The efficacy of gene therapy for the treatment of inherited immunodeficiency has been highlighted in recent clinical trials, although in some cases complicated…”
    Get more information
    Journal Article
  2. 2

    Haematopoietic repopulating activity in human cord blood [CD133.sup.+] quiescent cells by Boxall, S.A, Cook, G.P, Pearce, D, Bonnet, D, El-Sherbiny, Y.M, Blundell, M.P, Howe, S.J, Leek, J.P, Markham, A.F, de Wynter, E.A

    Published in Bone marrow transplantation (Basingstoke) (02-04-2009)
    “…We have demonstrated previously that cord blood [CD133.sup.+] cells isolated in the [G.sub.0] phase of the cell cycle are highly enriched for haematopoietic…”
    Get full text
    Journal Article
  3. 3

    Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector by LAURIE, K. L, BLUNDELL, M. P, BAXENDALE, H. E, HOWE, S. J, SINCLAIR, J, QASIM, W, BRUNSBERG, U, THRASHER, A. J, HOLMDAHL, R, GUSTAFSSON, K

    Published in Gene therapy (01-12-2007)
    “…The expression of genes specifically in B cells is of great interest in both experimental immunology as well as in future clinical gene therapy. We have…”
    Get full text
    Journal Article